NIH-led team sets new bar in retinal imaging
The mosaic of cone and rod photoreceptor cells is shown by confocal imaging (left) and split detection.
WHO adds Janssen vaccine to list of safe and effective emergency tools against COVID-19
The World Health Organization (WHO) on 12 March 2021 listed the COVID-19 vaccine Ad26.COV2.S, developed by Janssen (Johnson & Johnson), for emergency use in all countries and for COVAX roll-out. The decision comes on the back of the European...
Devastatingly pervasive: 1 in 3 women globally experience violence
iolence against women remains devastatingly pervasive and starts alarmingly young, shows new data from WHO and partners. Across their lifetime, 1 in 3 women, around 736 million, are subjected to physical or sexual violence by an intimate partner or...
New global breast cancer initiative highlights renewed commitment to improve survival
A major new collaborative effort, the Global Breast Cancer Initiative, is being introduced on Mar. 8 by the World Health Organization, with the objective of reducing global breast cancer mortality by 2.5% per year until 2040, thereby averting an...
CDC Issues First Set of Guidelines on How Fully Vaccinated People Can Visit Safely with Others
ar. 8, the Centers for Disease Control and Prevention (CDC) issued its first set of recommendations on activities that people who are fully vaccinated against COVID-19 can safely resume.
Statement on NIH starting enrollment for third trial of blood clotting treatments for COVID-19
The National Institutes of Health has launched the last of three Phase 3 clinical trials to evaluate the safety and effectiveness of blood thinners to prevent life-threatening blood clots in adults diagnosed with COVID-19. The first patient in the...
NIH-Sponsored ACTIV-3 Clinical Trial Closes Enrollment into Two Sub-Studies
Transmission electron micrograph of a SARS-CoV-2 virus particle (UK B.1.1.7 variant), isolated from a patient...
NIH scientists discover how DNA fragments can trigger inflammation in sickle cell disease
Scanning electron microscopy image of mitochondrial bundles in several sickle cell red blood cells...
IH to evaluate COVID-19 at-home testing system
A research team funded by the National Institutes of Health has launched a study to assess performance and usability of a smartphone app paired with the Quidel QuickVue At-Home COVID-19 Test, which just received an Emergency Use Authorization(link is...
NIH halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms
The National Institutes of Health has halted a clinical trial evaluating the safety and effectiveness of COVID-19 convalescent plasma in treating emergency department patients who developed mild to moderate symptoms of COVID-19, the disease caused by...
